The invincible opponent of hepatitis B will be criticized and will go on the market soon 20 million patients are expected to get the treatment

The invincible opponent of hepatitis B will be criticized and will go on the market soon 20 million patients are expected to get the treatment
Forest, reporter of New Bulletin, pacify high the intersection of intern and the intersection of favor and precious the intersection of reporter and ZengYan Zhu Xu reporter learn from academic meeting of hepatopathy of Guangdong Province yesterday, through the clinical trials of five years, therapeutic vaccine of hepatitis B has already finished the clinical stage of two, three successively, will obtain national food medicines soon and supervise the authentication code of administration bureau going on the market. This means the person who carries virus of 93 millionth hepatitis B in our country, 20 million patients' hepatitis B persistent ailment meet the strong invincible opponent. Vaccine can " Wake up " Immune cell, all the time, hepatitis B patient want, inhibit or lighten own condition with antiviral treatment method, but they meet a difficult problem, that is that the medicine will let the immune system be in paralrzed state slowly, can't prevent the erosion of the virus finally. It is reported, and the past biggest difference of therapeutic medicine of hepatitis B is, therapeutic vaccine of hepatitis B can " Wake up " The immune cells in the body of persons who carry, thus kill " sleeps " for the antiviral treatment Hepatitis B and virus create the condition, become " trump card " of hepatitis B and virus . Guangdong the intersection of south of the Five Ridges and hepatopathy the intersection of research institute and Yang, Deputy Director of managing, bright to tell reporter: "Therapeutic vaccine of hepatitis B can make serum hepatitis B and virus DNA of the patients of 64.3% turn overcast, 43% patient e antigenic serum changes. " " work along both lines " Treated effectually but citizens don't think either that used treatment vaccine of hepatitis B and solve all problems simply. Professor Yang tells reporters, want to achieve better result in the hepatitis B treatment, it is a therapeutic new route to regulate and unite the antiviral medicine, become the direction of hepatitis B treatment in the future too. Professor Yang says: "Vaccine can't replace the antiviral medicine, can't expect a piece of vaccine to solve hepatitis B all treat the problem. But if combine with antiviral medicine, the majority can achieve and inhibit hepatitis B and virus and duplicate, block its treatment that develops towards liver cirrhosis enduringly. " Expert remind, still have 70% patient adopt, protect liver fall the intersection of enzyme and these kind of palliative treatment of tackling a problem on the surface, not at the root while being single at present, come strictly and say it is one that is managed by mistake. It will lose the best opportunity of antiviral treatment of hepatitis B by mistake. And therapeutic immune modulator and antiviral medicine of vaccine of hepatitis B,etc. " Work along both lines " ,Can inhibit or remove hepatitis B and virus to the maximum extent, reach and face recuring in bed and high-efficient and low. New Bulletin

|